Literature DB >> 1632999

The patient's view of hypertension and compliance.

C M Sharkness1, D A Snow.   

Abstract

Noncompliance has been identified as the predominant reason for failure of hypertension therapy. Patients may perceive hypertension as a symptomatic condition, and this view may affect compliance. In a cross-sectional study of outpatients attending a hypertension clinic, we assessed 125 veterans' understanding of hypertension, hypertension history, comorbidities, and pharmacy refills for hypertension medications. Though over 70% viewed hypertension as a symptomatic condition, symptoms were not significantly associated with pharmacy compliance. In univariate analyses, variables significantly associated with better pharmacy compliance were perceived lifetime treatment of hypertension, greater than 5-year history of medication use, perceived cause of hypertension other than diet, use of more than one hypertension drug, lack of reported departure from the prescribed medication regimen, absence of drug abuse history, and race (Caucasian). In multivariate analyses, the best predictive model of pharmacy compliance included three variables: drug abuse history, perceived cause of hypertension, and pattern of medication use. This type of information should be included in the assessment of medication compliance among hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632999

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  29 in total

Review 1.  Compliance with prescribed drugs: challenges for the elderly population.

Authors:  S Claesson; A Morrison; A I Wertheimer; M L Berger
Journal:  Pharm World Sci       Date:  1999-12

Review 2.  Noncompliance with antihypertensive therapy. Economic consequences.

Authors:  T L Skaer; D A Sclar; L M Robison
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

Review 3.  Assessing medication adherence in the elderly: which tools to use in clinical practice?

Authors:  Eric J MacLaughlin; Cynthia L Raehl; Angela K Treadway; Teresa L Sterling; Dennis P Zoller; Chester A Bond
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

5.  Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.

Authors:  J J Caro; J L Speckman; M Salas; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

6.  Using the transtheoretical model's stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting.

Authors:  Yara Arafat; Mohamed Izham Mohamed Ibrahim; Ahmed Awaisu; Stephen Colagiuri; Yaw Owusu; Donald E Morisky; Mudather AlHafiz; Ahmed Yousif
Journal:  Daru       Date:  2019-02-07       Impact factor: 3.117

7.  Racial differences in medication adherence: A cross-sectional study of Medicare enrollees.

Authors:  Ben S Gerber; Young Ik Cho; Ahsan M Arozullah; Shoou-Yih D Lee
Journal:  Am J Geriatr Pharmacother       Date:  2010-04

8.  Differences and similarities in explanatory models of hypertension in the United States of america, Tanzania and Jamaica.

Authors:  J D Purakal; J Williams-Johnson; E W Williams; S Pemba; J Kambona; R Welch; J Flack; P Levy
Journal:  West Indian Med J       Date:  2014-06-11       Impact factor: 0.171

9.  Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.

Authors:  Willemien van de Water; Esther Bastiaannet; Elysée T M Hille; Elma M Meershoek-Klein Kranenbarg; Hein Putter; Caroline M Seynaeve; Robert Paridaens; Anton J M de Craen; Rudi G J Westendorp; Gerrit-Jan Liefers; Cornelis J H van de Velde
Journal:  Oncologist       Date:  2011-12-30

10.  Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors.

Authors:  Philip S Wang; Rhonda L Bohn; Eric Knight; Robert J Glynn; Helen Mogun; Jerry Avorn
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.